United Kingdom · Question · Written question
UIN 157048
Voluntary Scheme for Branded Medicines Pricing and Access
Introduced
2 March 2023
Last action
14 March 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
14 March 2023
Summary
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of a potential link between the rebate in the Voluntary Scheme for Branded Medicines Pricing and Access and (a) the level of foreign direct investment into UK life
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
2 March 2023
Written question
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of a potential link between the rebate in the Voluntary Scheme for Branded Medicines Pricing and Access and (a) the level of foreign direct investment into UK life
Source: Commons
14 March 2023
Answer
The Government has considered the link between changes to the volume-based rebate payments in our medicine pricing schemes and various kinds of investment, along with any associated impacts on employment in the life sciences industry in the United Kingdom...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-03-02/157048
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1600759
- uk · wq-1600759 · source updated 14 March 2023